In addition, increasing evidences had suggested that HMGA2 could facilitate 5-FU resistance in many cancers, like hepatoma cancer, colorectal cancer and breast cancer [21–23, 38, 39]. This evidence concerns the gene HMGA2 and breast carcinoma.